Description
Spartan Bioscience (Spartan) proposes development of a SARS-CoV-2 assay to operate on its Cube sample-to-result real-time PCR testing platform. The proposed assay will have a simple workflow requiring no sample preparation after sample coll…
Amendment chain · 3 entries
Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header. For this agreement: $273,928 at start, $687,928 after amendment #2 (+$414,000).
- #02020-03-23$273,928
- #12020-07-16$687,928+$414,000
- #22020-11-27$687,928
| Row | Date | Total value as of row | Change vs previous | Description on this row |
|---|---|---|---|---|
| #0 original | 2020-03-23(start date) | $273,928 | — | Spartan Bioscience (Spartan) proposes development of a SARS-CoV-2 assay to operate on its Cube sample-to-resul… |
| #1 amendment | 2020-07-16 | $687,928 | +$414,000 | Spartan Bioscience (Spartan) proposes development of a SARS-CoV-2 assay to operate on its Cube sample-to-resul… |
| #2 amendment | 2020-11-27 | $687,928 | +$0 | Spartan Bioscience (Spartan) proposes development of a SARS-CoV-2 assay to operate on its Cube sample-to-resul… |
Related records · 11
Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).
Other current agreements for the same recipient (business number 855952438)
| Ref | Department · program | Current value | FY |
|---|---|---|---|
| 062-2021-2022-Q4-00057 | Federal Economic Development Agency for Southern Ontario | Agence fédérale de développement économique pour le Sud de l'Ontario · Business Scale-Up | $2,833,986 | FY2021 |
| 062-2020-2021-Q4-00427 | Federal Economic Development Agency for Southern Ontario | Agence fédérale de développement économique pour le Sud de l'Ontario · Business Scale-Up | $2,833,986 | FY2021 |
| 172-2020-2021-Q2-953830 | National Research Council Canada | Conseil national de recherches Canada · CanExport SMEs | $75,000 | FY2021 |
| 271-2019-2020-Q4-00073 | Health Canada | Santé Canada · Canadian Health Systems and Programs | $150,000 | FY2020 |
| 172-2019-2020-Q3-936000 | National Research Council Canada | Conseil national de recherches Canada · CanExport SMEs | $74,625 | FY2020 |
| 172-2018-2019-Q2-912168 | National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Contributions to Firms | $349,000 | FY2019 |
Other recipients funded under "Industrial Research Assistance Program – Contributions to Firms" by National Research Council Canada | Conseil national de recherches Canada (most recent first)
| Ref | Recipient | Fiscal year | Current value | FY |
|---|---|---|---|---|
| 172-2025-2026-Q2-1034675 | Mediphage Bioceuticals, Inc. | FY2027 | $63,380 | FY2027 |
| 172-2025-2026-Q3-1037522 | OBKIO INC. | FY2026 | $50,000 | FY2026 |
| 172-2025-2026-Q3-1037889 | SERVICES DE DEVELOPPEMENT PROFESSIONELS SDP INC | FY2026 | $25,000 | FY2026 |
| 172-2025-2026-Q2-1034040 | Griffith Foods Limited | FY2026 | $54,880 | FY2026 |
| 172-2025-2026-Q3-1037273 | Apollo Machine & Welding Ltd. | FY2026 | $230,000 | FY2026 |
Cite as: Glassbox record view · Federal grants & contributions · 172-2019-2020-Q4-947397 · retrieved 2026-11-15.